Body weight is modulated by levels of full-length Huntingtin

Human Molecular Genetics

Volumn 15, Issue 9, 2006, Pages 1513-1523

  Van Raamsdonk, Jeremy M ^a,b   Gibson, William T ^a,b   Pearson, Jacqueline ^a,b   Murphy, Zoe ^a,b   Lu, Ge ^a,b   Leavitt, Blair R ^a,b   Hayden, Michael R ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; MUTANT PROTEIN; POLYGLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BRAIN WEIGHT; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; FOOD INTAKE; GENE OVEREXPRESSION; GENETIC CODE; HEART WEIGHT; KIDNEY MASS; LIVER WEIGHT; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN WEIGHT; TESTIS WEIGHT; WEIGHT GAIN; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; EATING; FEMALE; GENE EXPRESSION REGULATION; KIDNEY; MALE; MICE; MICE, INBRED STRAINS; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; ORGAN SIZE; SPLEEN;

ANIMALIA;

EID: 33646128019     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddl072     Document Type: Article

References (49)

1. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.G. and Hayden, M.R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell, 81, 811-823.
2. Cattaneo, E., Rigamonti, D., Goffredo, D., Zuccato, C., Squitieri, F. and Sipione, S. (2001) Loss of normal huntingtin function: New developments in Huntington's disease research. Trends Neurosci., 24, 182-188.
3. Cattaneo, E., Zuccato, C. and Tartari, M. (2005) Normal huntingtin function: An alternative approach to Huntington's disease. Nat. Rev. Neurosci., 6, 919-930.
4. Zeitlin, S., Liu, J.P., Chapman, D.L., Papaioannou, V.E. and Efstratiadis, A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet., 11, 155-163.
5. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.P., Gusella, J.F. and Joyner, A.L. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Science, 269, 407-410.
6. O'Kusky, J.R., Nasir, J., Cicchetti, F., Parent, A. and Hayden, M.R. (1999) Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene. Brain Res., 818, 468-479.
7. White, J.K., Auerbach, W., Duyao, M.P., Vonsattel, J.P., Gusella, J.F., Joyner, A.L. and Macdonald, M.E. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet., 17, 404-410.
8. Auerbach, W., Hurlbert, M.S., Hilditch-Maguire, P., Wadghiri, Y.Z., Wheeler, V.C., Cohen, S.I., Joyner, A.L., Macdonald, M.E. and Turnbull, D.H. (2001) The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum. Mol. Genet., 10, 2515-2523.
9. Dragatsis, I., Levine, M.S. and Zeitlin, S. (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet., 26, 300-306.
10. Rigamonti, D., Bauer, J.H., De Fraja, C., Conti, L., Sipione, S., Sciorati, C., Clementi, E., Hackam, A., Hayden, M.R., Li, Y. et al. (2000) Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci., 20, 3705-3713.
11. Ho, L.W., Brown, R., Maxwell, M., Wyttenbach, A. and Rubinsztein, D.C. (2001) Wild-type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease. J. Med. Genet., 38, 450-452.
12. Leavitt, B.R., Guttman, J.A., Hodgson, J.G., Kimel, G.H., Singaraja, R., Vogl, A.W. and Hayden, M.R. (2001) Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo. Am. J. Hum. Genet., 68, 313-324.
13. Zhang, Y., Ona, V.O., Li, M., Drozda, M., Dubois-Dauphin, M., Przedborski, S., Ferrante, R.J. and Friedlander, R.M. (2003) Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's disease. J. Neurochem., 87, 1184-1192.
14. Leavitt, B.R., Van Raamsdonk, J.M., Shehadeh, J., Fernandes, H.B., Graham, R.K., Murphy, Z., Raymond, L. and Hayden, M.R. (2006) Wild-type huntingtin protects against excitotoxicity. J. Neurochem., 96, 1121-1129.
15. Li, S.H. and Li, X.J. (2004) Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet., 20, 146-154.
16. Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B.R., Goffredo, D., Conti, L., Macdonald, M.E., Friedlander, R.M., Silani, V., Hayden, M.R. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science, 293, 493-498.
17. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B.R., Hayden, M.R., Timmusk, T. et al. (2003) Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 35, 76-83.
18. Szebenyi, G., Morfini, G.A., Babcock, A., Gould, M., Selkoe, K., Stenoien, D.L., Young, M., Faber, P.W., Macdonald, M.E., McPhaul, M.J. and Brady, S.T. (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron, 40, 41-52.
19. Gunawardena, S., Her, L.S., Brusch, R.G., Laymon, R.A., Niesman, I.R., Gordesky-Gold, B., Sintasath, L., Bonini, N.M. and Goldstein, L.S. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron, 40, 25-40.
20. Gauthier, L.R., Charrin, B.C., Borrell-Pages, M., Dompierre, J.P., Rangone, H., Cordelieres, F.P., De Mey, J., Macdonald, M.E., Lessmann, V., Humbert, S. and Saudou, F. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell, 118, 127-138.
21. Trushina, E., Dyer, R.B., Badger, J.D., Ure, D., Eide, L., Tran, D.D., Vrieze, B.T., Legendre-Guillemin, V., McPherson, P.S., Mandavilli, B.S. et al. (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol., 24, 8195-8209.
22. Hodgson, J.G., Agopyan, N., Gutekunst, C.A., Leavitt, B.R., LePiane, F., Singaraja, R., Smith, D.J., Bissada, N., McCutcheon, K., Nasir, J. et al. (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron, 23, 181-192.
23. Van Raamsdonk, J.M., Pearson, J., Rogers, D.A., Bissada, N., Vogl, A.W., Hayden, M.R. and Leavitt, B.R. (2005) Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease. Hum. Mol. Genet., 14, 1379-1392.
24. Wheeler, V.C., White, J.K., Gutekunst, C.A., Vrbanac, V., Weaver, M., Li, X.J., Li, S.H., Yi, H., Vonsattel, J.P., Gusella, J.F. et al. (2000) Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet., 9, 503-513.
25. Lin, C.H., Tallaksen-Greene, S., Chien, W.M., Cearley, J.A., Jackson, W.S., Crouse, A.B., Ren, S., Li, X.J., Albin, R.L. and Detloff, P.J. (2001) Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum. Mol. Genet., 10, 137-144.
26. Hodgson, J.G., Smith, D.J., McCutcheon, K., Koide, H.B., Nishiyama, K., Dinulos, M.B., Stevens, M.E., Bissada, N., Nasir, J., Kanazawa, I. et al. (1996) Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype. Hum. Mol. Genet., 5, 1875-1885.
27. Slow, E.J., van Raamsdonk, J., Rogers, D., Coleman, S.H., Graham, R.K., Deng, Y., Oh, R., Bissada, N., Hossain, S.M., Yang, Y.Z. et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum. Mol. Genet., 12, 1555-1567.
28. Van Raamsdonk, J.M., Pearson, J., Slow, E.J., Hossain, S.M., Leavitt, B.R. and Hayden, M.R. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci., 25, 4169-4180.
29. Slow, E.J., Graham, R.K., Osmand, A.P., Devon, R.S., Lu, G., Deng, Y., Pearson, J., Vaid, K., Bissada, N., Wetzel, R. et al. (2005) Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc. Natl Acad. Sci. USA, 102, 11402-11407.
30. Fain, J.N., Del Mar, N.A., Meade, C.A., Reiner, A. and Goldowitz, D. (2001) Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum. Mol. Genet., 10, 145-152.
31. Hurlbert, M.S., Zhou, W., Wasmeier, C., Kaddis, F.G., Hutton, J.C. and Freed, C.R. (1999) Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes, 48, 649-651.
32. Qian, S., Chen, H., Weingarth, D., Trumbauer, M.E., Novi, D.E., Guan, X., Yu, H., Shen, Z., Feng, Y., Frazier, E. et al. (2002) Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol. Cell. Biol., 22, 5027-5035.
33. Sharp, A.H., Loev, S.J., Schilling, G., Li, S.H., Li, X.J., Bao, J., Wagster, M.V., Kotzuk, J.A., Steiner, J.P. and Lo, A. (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron, 14, 1065-1074.
34. Reiner, A., Del Mar, N., Meade, C.A., Yang, H., Dragatsis, I., Zeitlin, S. and Goldowitz, D. (2001) Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice. J. Neurosci., 21, 7608-7619.
35. Metzler, M., Helgason, C.D., Dragatsis, I., Zhang, T., Gan, L., Pineault, N., Zeitlin, S.O., Humphries, R.K. and Hayden, M.R. (2000) Huntingtin is required for normal hematopoiesis. Hum. Mol. Genet., 9, 387-394.
36. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. and Bates, G.P. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
37. Schilling, G., Becher, M.W., Sharp, A.H., Jinnah, H.A., Duan, K., Kotzuk, J.A., Slunt, H.H., Ratovitski, T., Cooper, J.K., Jenkins, N.A. et al. (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet., 8, 397-407.
38. Zhang, Y., Li, M., Drozda, M., Chen, M., Ren, S., Mejia Sanchez, R.O., Leavitt, B.R., Cattaneo, E., Ferrante, R.J., Hayden, M.R. and Friedlander, R.M. (2003) Depletion of wild-type huntingtin in mouse models of neurologic diseases. J. Neurochem., 87, 101-106.
39. Reddy, P.H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W.O., Jr, Miller, G. and Tagle, D.A. (1998) Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet., 20, 198-202.
40. Djousse, L., Knowlton, B., Cupples, L.A., Marder, K., Shoulson, I. and Myers, R.H. (2002) Weight loss in early stage of Huntington's disease. Neurology, 59, 1325-1330.
41. Kremer, H.P. and Roos, R.A. (1992) Weight loss in Huntington's disease. Arch. Neurol., 49, 349.
42. Morales, L.M., Estevez, J., Suarez, H., Villalobos, R., Chacin, d.B. and Bonilla, E. (1989) Nutritional evaluation of Huntington disease patients. Am. J. Clin. Nutr., 50, 145-150.
43. Sanberg, P.R., Fibiger, H.C. and Mark, R.F. (1981) Body weight and dietary factors in Huntington's disease patients compared with matched controls. Med. J. Aust., 1, 407-409.
44. Pratley, R.E., Salbe, A.D., Ravussin, E. and Caviness, J.N. (2000) Higher sedentary energy expenditure in patients with Huntington's disease. Ann. Neurol., 47, 64-70.
45. Beal, M.F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta, 1366, 211-223.
46. Dixon, K.T., Cearley, J.A., Hunter, J.M. and Detloff, P.J. (2004) Mouse Huntington's disease homolog mRNA levels: Variation and allele effects. Gene Expr., 11, 221-231.
47. Schilling, G., Sharp, A.H., Loev, S.J., Wagster, M.V., Li, S.H., Stine, O.C. and Ross, C.A. (1995) Expression of the Huntington's disease (IT15) protein product in HD patients. Hum. Mol. Genet., 4, 1365-1371.
48. Ona, V.O., Li, M., Vonsattel, J.P., Andrews, L.J., Khan, S.Q., Chung, W.M., Frey, A.S., Menon, A.S., Li, X.J., Stieg, P.E. et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature, 399, 263-267.
49. Kunnecke, B., Verry, P., Benardeau, A. and von Kienlin, M. (2004) Quantitative body composition analysis in awake mice and rats by Magnetic Resonance Relaxometry. Obes. Res., 12, 1604-1615.